LION/repRNA-CoV2S

N/A

Report date: 2026/05/06 20:02:28

NME

Base Information

Drug NameLION/repRNA-CoV2S

Drug Alias NameLION/repRNA-CoV2SLION/repRNA-CoV-2-S

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccine

Mechanisms of ActionCoronavirus spike glycoprotein inhibitors

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Washington

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Washington

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A